Drug firm GlaxoSmithKline Pharmaceuticals Monday reported a 35 per cent rise in its standalone profit to Rs 113.54 crore for the first quarter ended June 30.
The company had posted a net profit of Rs 84.08 crore for the corresponding period previous fiscal, GlaxoSmithKline Pharmaceuticals said in a BSE filing.
Standalone total income of the company also rose to Rs 818.78 crore for the quarter under consideration as against Rs 753.66 crore in the same period a year ago.
Shares of GlaxoSmithKline Pharmaceuticals were trading at Rs 1,189 per scrip on the BSE, up 1.33 per cent from its previous close.
Disclaimer: No Business Standard Journalist was involved in creation of this content
